Global In - Vitro ADME Services Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global In - Vitro ADME Services Market Research Report 2024
In-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) services are a set of techniques used in drug development to assess the pharmacokinetic properties of a compound before it is tested in animals or humans. These services involve the use of in-vitro assays to measure how a compound is absorbed, distributed, metabolized, and eliminated by the body. In-vitro ADME services can provide critical information about a compound's potential efficacy and safety profile, and can help identify potential issues early in the drug development process.
According to MRAResearch’s new survey, global In - Vitro ADME Services market is projected to reach US$ 1543.7 million in 2033, increasing from US$ 870.2 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In - Vitro ADME Services market research.
Global In - Vitro ADME Services companies include Charles River, Labcorp, Envigo, Curia and Evotec. Global top 3 companies hold a share over 32%. North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacific. In terms of product type, Small Molecules is the largest segment, with a share about 80%. In terms of end user, the largest user is Biopharmaceutical Companies, with a share about 80%, followed by Government and Academic Institutes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In - Vitro ADME Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In - Vitro ADME Services report covers below items
Chapter 1Product Basic Information (Definition, Type and End User)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product End User Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global In - Vitro ADME Services market is projected to reach US$ 1543.7 million in 2033, increasing from US$ 870.2 million in 2022, with the CAGR of 8.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In - Vitro ADME Services market research.
Global In - Vitro ADME Services companies include Charles River, Labcorp, Envigo, Curia and Evotec. Global top 3 companies hold a share over 32%. North America is the largest market, with a share about 47%, followed by Europe and Asia-Pacific. In terms of product type, Small Molecules is the largest segment, with a share about 80%. In terms of end user, the largest user is Biopharmaceutical Companies, with a share about 80%, followed by Government and Academic Institutes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In - Vitro ADME Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Charles River
Labcorp
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by End User
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In - Vitro ADME Services report covers below items
Chapter 1Product Basic Information (Definition, Type and End User)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product End User Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source